18 results on '"Riemers, Frank M."'
Search Results
2. Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance
- Author
-
Segeren, Hendrika A., Wierenga, Kathryn A., Riemers, Frank M., Liere, Elsbeth A. van, Westendorp, Bart, Segeren, Hendrika A., Wierenga, Kathryn A., Riemers, Frank M., Liere, Elsbeth A. van, and Westendorp, Bart
- Abstract
Oncogene-induced replication stress (RS) is a vulnerability of cancer cells that forces reliance on the intra-S-phase checkpoint to ensure faithful genome duplication. Inhibitors of the crucial intra-S-phase checkpoint kinases ATR and CHK1 have been developed, but persistent proliferation and resistance to these drugs remain problematic. Understanding drug tolerance mechanisms is impeded by analysis of bulk samples, which neglect tumor heterogeneity and often fail to accurately interpret cell cycle-mediated resistance. Here, by combining intracellular immunostaining and RNA-sequencing of single cells, we characterized the transcriptomes of oncogenic RAS-expressing cells that exhibit variable levels of RS when challenged with a CHK1 inhibitor in combination with the chemotherapeutic drug gemcitabine. We identified 40 genes differentially expressed between tolerant and sensitive cells, including several FOXM1 target genes. While complete knockdown of FOXM1 impeded cell proliferation, a partial knockdown protected cells against DNA damage, and improved recovery from drug-induced RS. Our results suggest that low levels of FOXM1 expression protects subsets of oncogenic RAS-expressing cells against DNA damage during drug-induced replication stress.
- Published
- 2024
3. Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance
- Author
-
Pathobiologie, Chirurgie, CS_Locomotion, Cell Biology, Metabolism & Cancer - Cancer, Locomotion - Surgery (CA), Segeren, Hendrika A., Wierenga, Kathryn A., Riemers, Frank M., Liere, Elsbeth A. van, Westendorp, Bart, Pathobiologie, Chirurgie, CS_Locomotion, Cell Biology, Metabolism & Cancer - Cancer, Locomotion - Surgery (CA), Segeren, Hendrika A., Wierenga, Kathryn A., Riemers, Frank M., Liere, Elsbeth A. van, and Westendorp, Bart
- Published
- 2024
4. Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance.
- Author
-
Segeren, Hendrika A., primary, Wierenga, Kathryn A., additional, Riemers, Frank M., additional, van Liere, Elsbeth A., additional, and Westendorp, Bart, additional
- Published
- 2024
- Full Text
- View/download PDF
5. Single cell analysis of docosahexaenoic acid suppression of sequential LPS-induced proinflammatory and interferon-regulated gene expression in the macrophage
- Author
-
Wierenga, Kathryn A, Riemers, Frank M, Westendorp, Bart, Harkema, Jack R, Pestka, James J, Chirurgie, CS_Locomotion, Pathobiologie, Chirurgie, CS_Locomotion, and Pathobiologie
- Subjects
Lipopolysaccharides ,Docosahexaenoic Acids ,Macrophages ,IFN signaling ,Immunology ,NF-kappa B ,Gene Expression ,macrophage ,scRNAseq ,Toll-Like Receptor 4 ,cholesterolmetabolism ,Mice ,Fatty Acids, Omega-3 ,Animals ,Cytokines ,inflammatory gene expression ,Immunology and Allergy ,Interferons ,NF-kB ,Single-Cell Analysis ,TLR4 signaling ,omega-3 polyunsaturated fatty acids - Abstract
Preclinical and clinical studies suggest that consumption of long chain omega-3 polyunsaturated fatty acids (PUFAs) reduces severity of chronic inflammatory and autoimmune diseases. While these ameliorative effects are conventionally associated with downregulated expression of proinflammatory cytokine and chemokine genes, our laboratory has recently identified Type 1 interferon (IFN1)-regulated gene expression to be another key target of omega-3 PUFAs. Here we used single cell RNA sequencing (scRNAseq) to gain new mechanistic perspectives on how the omega-3 PUFA docosahexaenoic acid (DHA) influences TLR4-driven proinflammatory and IFN1-regulated gene expression in a novel self-renewing murine fetal liver-derived macrophage (FLM) model. FLMs were cultured with 25 µM DHA or vehicle for 24 h, treated with modest concentration of LPS (20 ng/ml) for 1 and 4 h, and then subjected to scRNAseq using the 10X Chromium System. At 0 h (i.e., in the absence of LPS), DHA increased expression of genes associated with the NRF2 antioxidant response (e.g. Sqstm1, Hmox1, Chchd10) and metal homeostasis (e.g.Mt1, Mt2, Ftl1, Fth1), both of which are consistent with DHA-induced polarization of FLMs to a more anti-inflammatory phenotype. At 1 h post-LPS treatment, DHA inhibited LPS-induced cholesterol synthesis genes (e.g. Scd1, Scd2, Pmvk, Cyp51, Hmgcs1, and Fdps) which potentially could contribute to interference with TLR4-mediated inflammatory signaling. At 4 h post-LPS treatment, LPS-treated FLMs reflected a more robust inflammatory response including upregulation of proinflammatory cytokine (e.g. Il1a, Il1b, Tnf) and chemokine (e.g.Ccl2, Ccl3, Ccl4, Ccl7) genes as well as IFN1-regulated genes (e.g. Irf7, Mx1, Oasl1, Ifit1), many of which were suppressed by DHA. Using single-cell regulatory network inference and clustering (SCENIC) to identify gene expression networks, we found DHA modestly downregulated LPS-induced expression of NF-κB-target genes. Importantly, LPS induced a subset of FLMs simultaneously expressing NF-κB- and IRF7/STAT1/STAT2-target genes that were conspicuously absent in DHA-pretreated FLMs. Thus, DHA potently targeted both the NF-κB and the IFN1 responses. Altogether, scRNAseq generated a valuable dataset that provides new insights into multiple overlapping mechanisms by which DHA may transcriptionally or post-transcriptionally regulate LPS-induced proinflammatory and IFN1-driven responses in macrophages.
- Published
- 2022
- Full Text
- View/download PDF
6. Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53
- Author
-
Pathobiologie, dPB RMSC, Chirurgie, dCSCA RMSC-1, Dep Biomolecular Health Sciences, CS_Locomotion, Segeren, Hendrika A, van Liere, Elsbeth A, Riemers, Frank M, de Bruin, Alain, Westendorp, Bart, Pathobiologie, dPB RMSC, Chirurgie, dCSCA RMSC-1, Dep Biomolecular Health Sciences, CS_Locomotion, Segeren, Hendrika A, van Liere, Elsbeth A, Riemers, Frank M, de Bruin, Alain, and Westendorp, Bart
- Published
- 2022
7. Folate Receptor Expression by Human Monocyte-Derived Macrophage Subtypes and Effects of Corticosteroids
- Author
-
Chirurgie, dCSCA RMSC-1, Equine Musculoskeletal Biology, dES RMSC, Dep Clinical Sciences, CS_Locomotion, Warmink, Kelly, Siebelt, Michiel, Low, Philip S, Riemers, Frank M, Wang, Bingbing, Plomp, Saskia G M, Tryfonidou, Marianna A, van Weeren, P René, Weinans, Harrie, Korthagen, Nicoline M, Chirurgie, dCSCA RMSC-1, Equine Musculoskeletal Biology, dES RMSC, Dep Clinical Sciences, CS_Locomotion, Warmink, Kelly, Siebelt, Michiel, Low, Philip S, Riemers, Frank M, Wang, Bingbing, Plomp, Saskia G M, Tryfonidou, Marianna A, van Weeren, P René, Weinans, Harrie, and Korthagen, Nicoline M
- Published
- 2022
8. Single cell analysis of docosahexaenoic acid suppression of sequential LPS-induced proinflammatory and interferon-regulated gene expression in the macrophage
- Author
-
Chirurgie, CS_Locomotion, Pathobiologie, Wierenga, Kathryn A, Riemers, Frank M, Westendorp, Bart, Harkema, Jack R, Pestka, James J, Chirurgie, CS_Locomotion, Pathobiologie, Wierenga, Kathryn A, Riemers, Frank M, Westendorp, Bart, Harkema, Jack R, and Pestka, James J
- Published
- 2022
9. Folate Receptor Expression by Human Monocyte-Derived Macrophage Subtypes and Effects of Corticosteroids
- Author
-
ORT Research, Regenerative Medicine and Stem Cells, Orthopaedie Onderzoek, Other research (not in main researchprogram), Warmink, Kelly, Siebelt, Michiel, Low, Philip S, Riemers, Frank M, Wang, Bingbing, Plomp, Saskia G M, Tryfonidou, Marianna A, van Weeren, P René, Weinans, Harrie, Korthagen, Nicoline M, ORT Research, Regenerative Medicine and Stem Cells, Orthopaedie Onderzoek, Other research (not in main researchprogram), Warmink, Kelly, Siebelt, Michiel, Low, Philip S, Riemers, Frank M, Wang, Bingbing, Plomp, Saskia G M, Tryfonidou, Marianna A, van Weeren, P René, Weinans, Harrie, and Korthagen, Nicoline M
- Published
- 2022
10. Notochordal Cell-Based Treatment Strategies and Their Potential in Intervertebral Disc Regeneration
- Author
-
Bach, Frances C, Poramba-Liyanage, Deepani W, Riemers, Frank M, Guicheux, Jerome, Camus, Anne, Iatridis, James C, Chan, Danny, Ito, Keita, Le Maitre, Christine L, Tryfonidou, Marianna A, Chirurgie, dCSCA RMSC-1, CS_Locomotion, Utrecht University [Utrecht], RMeS - Regenerative Medicine of Bone Tissues (RMeS-REGOS), Université d'Angers (UA)-Regenerative Medicine and Skeleton (RMeS), École nationale vétérinaire, agroalimentaire et de l'alimentation Nantes-Atlantique (ONIRIS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR Odontologie, Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-École nationale vétérinaire, agroalimentaire et de l'alimentation Nantes-Atlantique (ONIRIS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR Odontologie, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Nantes Université - UFR Odontologie, PHU 4 OTONN [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), École nationale vétérinaire, agroalimentaire et de l'alimentation Nantes-Atlantique (ONIRIS), Icahn School of Medicine at Mount Sinai [New York] (MSSM), The University of Hong Kong (HKU), Eindhoven University of Technology [Eindhoven] (TU/e), University Medical Center [Utrecht], Sheffield Hallam University, CAMUS, ANNE, Chirurgie, dCSCA RMSC-1, and CS_Locomotion
- Subjects
[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO] ,[SDV]Life Sciences [q-bio] ,[SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC] ,[SDV.GEN.GA] Life Sciences [q-bio]/Genetics/Animal genetics ,[SDV.BC.IC] Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB] ,[SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology ,Notochordal cell ,[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,intervertebral disc – degeneration ,[SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB] ,[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO] ,[SDV.BC.BC] Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC] ,extracellularmatrix (ECM) ,low back pain ,[SDV.MHEP.RSOA] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system ,[SDV.BDD.EO] Life Sciences [q-bio]/Development Biology/Embryology and Organogenesis ,[SDV.BDD.MOR]Life Sciences [q-bio]/Development Biology/Morphogenesis ,[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology ,Cell Biology ,extracellular matrix (ECM) ,[SDV.BDD.MOR] Life Sciences [q-bio]/Development Biology/Morphogenesis ,[SDV] Life Sciences [q-bio] ,secretome ,[SDV.GEN.GA]Life Sciences [q-bio]/Genetics/Animal genetics ,[SDV.BDD.EO]Life Sciences [q-bio]/Development Biology/Embryology and Organogenesis ,[SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system ,cell therapeutic potential ,[SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,conditioned media (CM) ,Developmental Biology - Abstract
International audience; Chronic low back pain is the number one cause of years lived with disability. In about 40% of patients, chronic lower back pain is related to intervertebral disc (IVD) degeneration. The standard-of-care focuses on symptomatic relief, while surgery is the last resort. Emerging therapeutic strategies target the underlying cause of IVD degeneration and increasingly focus on the relatively overlooked notochordal cells (NCs). NCs are derived from the notochord and once the notochord regresses they remain in the core of the developing IVD, the nucleus pulposus. The large vacuolated NCs rapidly decline after birth and are replaced by the smaller nucleus pulposus cells with maturation, ageing, and degeneration. Here, we provide an update on the journey of NCs and discuss the cell markers and tools that can be used to study their fate and regenerative capacity. We review the therapeutic potential of NCs for the treatment of IVD-related lower back pain and outline important future directions in this area. Promising studies indicate that NCs and their secretome exerts regenerative effects, via increased proliferation, extracellular matrix production, and anti-inflammatory effects. Reports on NC-like cells derived from embryonic- or induced pluripotent-stem cells claim to have successfully generated NC-like cells but did not compare them with native NCs for phenotypic markers or in terms of their regenerative capacity. Altogether, this is an emerging and active field of research with exciting possibilities. NC-based studies demonstrate that cues from developmental biology can pave the path for future clinical therapies focused on regenerating the diseased IVD.
- Published
- 2022
- Full Text
- View/download PDF
11. sj-docx-2-car-10.1177_19476035221081469 ��� Supplemental material for Folate Receptor Expression by Human Monocyte���Derived Macrophage Subtypes and Effects of Corticosteroids
- Author
-
Warmink, Kelly, Siebelt, Michiel, Low, Philip S., Riemers, Frank M., Wang, Bingbing, Plomp, Saskia G. M., Tryfonidou, Marianna A., van Weeren, P. Ren��, Weinans, Harrie, and Korthagen, Nicoline M.
- Subjects
FOS: Clinical medicine ,FOS: Biological sciences ,110323 Surgery ,110604 Sports Medicine ,FOS: Health sciences ,69999 Biological Sciences not elsewhere classified ,110314 Orthopaedics - Abstract
Supplemental material, sj-docx-2-car-10.1177_19476035221081469 for Folate Receptor Expression by Human Monocyte���Derived Macrophage Subtypes and Effects of Corticosteroids by Kelly Warmink, Michiel Siebelt, Philip S. Low, Frank M. Riemers, Bingbing Wang, Saskia G. M. Plomp, Marianna A. Tryfonidou, P. Ren�� van Weeren, Harrie Weinans and Nicoline M. Korthagen in CARTILAGE
- Published
- 2022
- Full Text
- View/download PDF
12. Folate Receptor Expression by Human Monocyte-Derived Macrophage Subtypes and Effects of Corticosteroids
- Author
-
Warmink, Kelly, Siebelt, Michiel, Low, Philip S, Riemers, Frank M, Wang, Bingbing, Plomp, Saskia G M, Tryfonidou, Marianna A, van Weeren, P René, Weinans, Harrie, Korthagen, Nicoline M, Chirurgie, dCSCA RMSC-1, Equine Musculoskeletal Biology, dES RMSC, Dep Clinical Sciences, CS_Locomotion, Chirurgie, dCSCA RMSC-1, Equine Musculoskeletal Biology, dES RMSC, Dep Clinical Sciences, CS_Locomotion, and Orthopedics and Sports Medicine
- Subjects
Physical Therapy ,Macrophage Colony-Stimulating Factor ,M1/M2 ,Biomedical Engineering ,Granulocyte-Macrophage Colony-Stimulating Factor ,Physical Therapy, Sports Therapy and Rehabilitation ,Sports Therapy and Rehabilitation ,corticosteroids ,macrophages ,disease marker ,Folic Acid ,SDG 3 - Good Health and Well-being ,FR-beta ,Adrenal Cortex Hormones ,Humans ,Immunology and Allergy ,Folate Receptor 2 ,Biomarkers - Abstract
Objective Folate receptor beta (FR-β) has been used as a clinical marker and target in multiple inflammatory diseases, including osteoarthritis (OA) and rheumatoid arthritis (RA). However, the conditions under which FR-β+ macrophages arise remain unclear and could be affected by corticosteroids. Therefore, we studied FR-β expression in vitro in macrophage subtypes and determined their response to triamcinolone acetonide (TA), a clinically often-used corticosteroid. Design Human monocyte–derived macrophages were differentiated to the known M0, M1, or M2 macrophage phenotypes. The phenotype and FR-β expression and plasticity of the macrophage subtypes were determined using flow cytometry, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and enzyme-linked immunosorbent assay (ELISA). Results FR-β expression was low in granulocyte-macrophage colony-stimulating factor (GM-CSF)-generated (M1-like) macrophages and high in macrophage colony-stimulating factor (M-CSF)-generated (M0 and M2-like) macrophages. FR-β expression remained high once the M0 or M2 macrophages were stimulated with pro-inflammatory stimuli (interferon-γ plus lipopolysaccharide) to induce M1-like macrophages. On the contrary, anti-inflammatory TA treatment skewed GM-CSF macrophage differentiation toward an M2 and FR-β+ phenotype. Conclusions As corticosteroids skewed monocytes toward an FR-β-expressing, anti-inflammatory phenotype, even in an M1 priming GM-CSF environment, FR-β has potential as a biomarker to monitor success of treatment with corticosteroids. Without corticosteroid treatment, M-CSF alone induces high FR-β expression which remains high under pro-inflammatory conditions. This explains why pro-inflammatory FR-β+ macrophages (exposed to M-CSF) are observed in arthritis patients and correlate with disease severity.
- Published
- 2022
13. sj-docx-1-car-10.1177_19476035221081469 ��� Supplemental material for Folate Receptor Expression by Human Monocyte���Derived Macrophage Subtypes and Effects of Corticosteroids
- Author
-
Warmink, Kelly, Siebelt, Michiel, Low, Philip S., Riemers, Frank M., Wang, Bingbing, Plomp, Saskia G. M., Tryfonidou, Marianna A., van Weeren, P. Ren��, Weinans, Harrie, and Korthagen, Nicoline M.
- Subjects
FOS: Clinical medicine ,FOS: Biological sciences ,110323 Surgery ,110604 Sports Medicine ,FOS: Health sciences ,69999 Biological Sciences not elsewhere classified ,110314 Orthopaedics - Abstract
Supplemental material, sj-docx-1-car-10.1177_19476035221081469 for Folate Receptor Expression by Human Monocyte���Derived Macrophage Subtypes and Effects of Corticosteroids by Kelly Warmink, Michiel Siebelt, Philip S. Low, Frank M. Riemers, Bingbing Wang, Saskia G. M. Plomp, Marianna A. Tryfonidou, P. Ren�� van Weeren, Harrie Weinans and Nicoline M. Korthagen in CARTILAGE
- Published
- 2022
- Full Text
- View/download PDF
14. Enhanced Extracellular Matrix Breakdown Characterizes the Early Distraction Phase of Canine Knee Joint Distraction
- Author
-
Teunissen, Michelle, Miranda Bedate, Alberto, Coeleveld, Katja, Riemers, Frank M, Meij, Björn P, Lafeber, Floris P J G, Tryfonidou, Marianna A, Mastbergen, Simon C, Chirurgie, dCSCA RMSC-1, CS_Locomotion, Chirurgie, dCSCA RMSC-1, and CS_Locomotion
- Subjects
musculoskeletal diseases ,Knee Joint ,Physical Therapy ,education ,Biomedical Engineering ,Physical Therapy, Sports Therapy and Rehabilitation ,Osteoarthritis ,Sports Therapy and Rehabilitation ,Extracellular matrix ,03 medical and health sciences ,0302 clinical medicine ,Dogs ,Distraction ,Medicine ,Animals ,Humans ,Immunology and Allergy ,groove model ,Cartilage repair ,cartilage regeneration ,Collagen Type II ,Clinical Research papers ,030304 developmental biology ,030203 arthritis & rheumatology ,Orthodontics ,0303 health sciences ,business.industry ,medicine.disease ,Techniques ,Extracellular Matrix ,osteoarthritis ,Cartilage ,business - Abstract
Objective Joint distraction triggers intrinsic cartilage repair in animal models of osteoarthritis (OA), corroborating observations in human OA patients treated with joint distraction. The present study explores the still largely elusive mechanism initiating this repair process. Design Unilateral OA was induced in the knee joint of 8 dogs using the groove model; the contralateral joint served as a control. After 10 weeks, 4 animals received joint distraction, the other 4 serving as OA controls. Halfway the distraction period (after 4 weeks of a standard 8-week distraction treatment), all animals were euthanized, and joint tissues were collected. A targeted quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis was performed of commonly involved processes including matrix catabolism/anabolism, inflammation, and known signaling pathways in OA. In addition, cartilage changes were determined on tissue sections using the canine OARSI (Osteoarthritis Research Society International) histopathology score and collagen type II (COL2A1) immunostaining. Results Midway distraction, the distracted OA joint showed an upregulation of proteolytic genes, for example, ADAMTS5, MMP9, MMP13, compared to OA alone and the healthy joints, which correlated with an increased OARSI score. Additionally, genes of the transforming growth factor (TGF)-β and Notch pathway, and markers associated with progenitor cells were increased. Conclusions Joint distraction initiates both catabolic and anabolic transcriptional responses. The enhanced turnover, and thereby renewal of the matrix, could be the key to the cartilage repair observed in the months after joint distraction.
- Published
- 2021
15. Isolation and tracing of matrix-producing notochordal and chondrocyte cells using ACAN-2A-mScarlet reporter human iPSC lines.
- Author
-
Tong X, Poramba-Liyanage DW, van Hoolwerff M, Riemers FM, Montilla-Rojo J, Warin J, Salvatori D, Camus A, Meulenbelt I, Ramos YFM, Geijsen N, Tryfonidou MA, and Shang P
- Subjects
- Humans, Cell Line, Extracellular Matrix metabolism, Induced Pluripotent Stem Cells metabolism, Induced Pluripotent Stem Cells cytology, Chondrocytes metabolism, Chondrocytes cytology, Cell Differentiation, Aggrecans metabolism, Aggrecans genetics, Notochord metabolism, Notochord cytology, Genes, Reporter
- Abstract
The development of human induced pluripotent stem cell (iPSC)-based regenerative therapies is challenged by the lack of specific cell markers to isolate differentiated cell types and improve differentiation protocols. This issue is particularly critical for notochordal-like cells and chondrocytes, which are crucial in treating back pain and osteoarthritis, respectively. Both cell types produce abundant proteoglycan aggrecan (ACAN), crucial for the extracellular matrix. We generated two human iPSC lines containing an ACAN-2A-mScarlet reporter. The reporter cell lines were validated using CRISPR-mediated transactivation and functionally validated during notochord and cartilage differentiation. The ability to isolate differentiated cell populations producing ACAN enables their enrichment even in the absence of specific cell markers and allows for comprehensive studies and protocol refinement. ACAN's prevalence in various tissues (e.g., cardiac and cerebral) underscores the reporter's versatility as a valuable tool for tracking matrix protein production in diverse cell types, benefiting developmental biology, matrix pathophysiology, and regenerative medicine.
- Published
- 2024
- Full Text
- View/download PDF
16. Notochordal Cell-Based Treatment Strategies and Their Potential in Intervertebral Disc Regeneration.
- Author
-
Bach FC, Poramba-Liyanage DW, Riemers FM, Guicheux J, Camus A, Iatridis JC, Chan D, Ito K, Le Maitre CL, and Tryfonidou MA
- Abstract
Chronic low back pain is the number one cause of years lived with disability. In about 40% of patients, chronic lower back pain is related to intervertebral disc (IVD) degeneration. The standard-of-care focuses on symptomatic relief, while surgery is the last resort. Emerging therapeutic strategies target the underlying cause of IVD degeneration and increasingly focus on the relatively overlooked notochordal cells (NCs). NCs are derived from the notochord and once the notochord regresses they remain in the core of the developing IVD, the nucleus pulposus. The large vacuolated NCs rapidly decline after birth and are replaced by the smaller nucleus pulposus cells with maturation, ageing, and degeneration. Here, we provide an update on the journey of NCs and discuss the cell markers and tools that can be used to study their fate and regenerative capacity. We review the therapeutic potential of NCs for the treatment of IVD-related lower back pain and outline important future directions in this area. Promising studies indicate that NCs and their secretome exerts regenerative effects, via increased proliferation, extracellular matrix production, and anti-inflammatory effects. Reports on NC-like cells derived from embryonic- or induced pluripotent-stem cells claim to have successfully generated NC-like cells but did not compare them with native NCs for phenotypic markers or in terms of their regenerative capacity. Altogether, this is an emerging and active field of research with exciting possibilities. NC-based studies demonstrate that cues from developmental biology can pave the path for future clinical therapies focused on regenerating the diseased IVD., Competing Interests: KI is a paid consultant and shareholder at NC Biomatrix BV. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Bach, Poramba-Liyanage, Riemers, Guicheux, Camus, Iatridis, Chan, Ito, Le Maitre and Tryfonidou.)
- Published
- 2022
- Full Text
- View/download PDF
17. Folate Receptor Expression by Human Monocyte-Derived Macrophage Subtypes and Effects of Corticosteroids.
- Author
-
Warmink K, Siebelt M, Low PS, Riemers FM, Wang B, Plomp SGM, Tryfonidou MA, van Weeren PR, Weinans H, and Korthagen NM
- Subjects
- Biomarkers metabolism, Folic Acid metabolism, Humans, Macrophage Colony-Stimulating Factor metabolism, Macrophage Colony-Stimulating Factor pharmacology, Adrenal Cortex Hormones, Folate Receptor 2 metabolism, Granulocyte-Macrophage Colony-Stimulating Factor metabolism, Granulocyte-Macrophage Colony-Stimulating Factor pharmacology, Macrophages
- Abstract
Objective: Folate receptor beta (FR-β) has been used as a clinical marker and target in multiple inflammatory diseases, including osteoarthritis (OA) and rheumatoid arthritis (RA). However, the conditions under which FR-β
+ macrophages arise remain unclear and could be affected by corticosteroids. Therefore, we studied FR-β expression in vitro in macrophage subtypes and determined their response to triamcinolone acetonide (TA), a clinically often-used corticosteroid., Design: Human monocyte-derived macrophages were differentiated to the known M0, M1, or M2 macrophage phenotypes. The phenotype and FR-β expression and plasticity of the macrophage subtypes were determined using flow cytometry, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and enzyme-linked immunosorbent assay (ELISA)., Results: FR-β expression was low in granulocyte-macrophage colony-stimulating factor (GM-CSF)-generated (M1-like) macrophages and high in macrophage colony-stimulating factor (M-CSF)-generated (M0 and M2-like) macrophages. FR-β expression remained high once the M0 or M2 macrophages were stimulated with pro-inflammatory stimuli (interferon-γ plus lipopolysaccharide) to induce M1-like macrophages. On the contrary, anti-inflammatory TA treatment skewed GM-CSF macrophage differentiation toward an M2 and FR-β+ phenotype., Conclusions: As corticosteroids skewed monocytes toward an FR-β-expressing, anti-inflammatory phenotype, even in an M1 priming GM-CSF environment, FR-β has potential as a biomarker to monitor success of treatment with corticosteroids. Without corticosteroid treatment, M-CSF alone induces high FR-β expression which remains high under pro-inflammatory conditions. This explains why pro-inflammatory FR-β+ macrophages (exposed to M-CSF) are observed in arthritis patients and correlate with disease severity.- Published
- 2022
- Full Text
- View/download PDF
18. Enhanced Extracellular Matrix Breakdown Characterizes the Early Distraction Phase of Canine Knee Joint Distraction.
- Author
-
Teunissen M, Miranda Bedate A, Coeleveld K, Riemers FM, Meij BP, Lafeber FPJG, Tryfonidou MA, and Mastbergen SC
- Subjects
- Animals, Cartilage metabolism, Collagen Type II metabolism, Dogs, Extracellular Matrix metabolism, Humans, Knee Joint pathology, Osteoarthritis metabolism
- Abstract
Objective: Joint distraction triggers intrinsic cartilage repair in animal models of osteoarthritis (OA), corroborating observations in human OA patients treated with joint distraction. The present study explores the still largely elusive mechanism initiating this repair process., Design: Unilateral OA was induced in the knee joint of 8 dogs using the groove model; the contralateral joint served as a control. After 10 weeks, 4 animals received joint distraction, the other 4 serving as OA controls. Halfway the distraction period (after 4 weeks of a standard 8-week distraction treatment), all animals were euthanized, and joint tissues were collected. A targeted quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis was performed of commonly involved processes including matrix catabolism/anabolism, inflammation, and known signaling pathways in OA. In addition, cartilage changes were determined on tissue sections using the canine OARSI (Osteoarthritis Research Society International) histopathology score and collagen type II (COL2A1) immunostaining., Results: Midway distraction, the distracted OA joint showed an upregulation of proteolytic genes, for example, ADAMTS5 , MMP9 , MMP13 , compared to OA alone and the healthy joints, which correlated with an increased OARSI score. Additionally, genes of the transforming growth factor (TGF)-β and Notch pathway, and markers associated with progenitor cells were increased., Conclusions: Joint distraction initiates both catabolic and anabolic transcriptional responses. The enhanced turnover, and thereby renewal of the matrix, could be the key to the cartilage repair observed in the months after joint distraction.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.